284 related articles for article (PubMed ID: 18292205)
1. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels.
Tao J; Hildebrand ME; Liao P; Liang MC; Tan G; Li S; Snutch TP; Soong TW
Mol Pharmacol; 2008 Jun; 73(6):1596-609. PubMed ID: 18292205
[TBL] [Abstract][Full Text] [Related]
2. Activation of corticotropin-releasing factor 2 receptor inhibits Purkinje neuron P-type calcium currents via G(o)alpha-dependent PKC epsilon pathway.
Tao J; Zhang Y; Huang H; Jiang X
Cell Signal; 2009 Sep; 21(9):1436-43. PubMed ID: 19439178
[TBL] [Abstract][Full Text] [Related]
3. Regulation of somatodendritic dopamine release by corticotropin-releasing factor via the inhibition of voltage-operated Ca2+ channels.
Kim Y; Park MK; Chung S
Neurosci Lett; 2009 Nov; 465(1):31-5. PubMed ID: 19729048
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes.
Smani T; Calderón-Sanchez E; Gómez-Hurtado N; Fernández-Velasco M; Cachofeiro V; Lahera V; Ordoñez A; Delgado C
Cardiovasc Res; 2010 Aug; 87(3):459-66. PubMed ID: 20189952
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C-mediated inhibition of recombinant T-type Cav3.2 channels by neurokinin 1 receptors.
Rangel A; Sánchez-Armass S; Meza U
Mol Pharmacol; 2010 Feb; 77(2):202-10. PubMed ID: 19805509
[TBL] [Abstract][Full Text] [Related]
6. Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells.
Kim Y; Park MK; Uhm DY; Chung S
Biochem Biophys Res Commun; 2007 Jul; 358(3):796-801. PubMed ID: 17506983
[TBL] [Abstract][Full Text] [Related]
7. CRF-induced calcium signaling in guinea pig small intestine myenteric neurons involves CRF-1 receptors and activation of voltage-sensitive calcium channels.
Bisschops R; Vanden Berghe P; Sarnelli G; Janssens J; Tack J
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1252-60. PubMed ID: 16384874
[TBL] [Abstract][Full Text] [Related]
8. CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels.
You H; Altier C; Zamponi GW
Mol Pharmacol; 2010 Feb; 77(2):211-7. PubMed ID: 19864434
[TBL] [Abstract][Full Text] [Related]
9. Effects of urocortin on T-type calcium currents in mouse spermatogenic cells.
Tao J; Wu Y; Chen J; Zhu H; Li S
Biochem Biophys Res Commun; 2005 Apr; 329(2):743-8. PubMed ID: 15737649
[TBL] [Abstract][Full Text] [Related]
10. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.
Dautzenberg FM; Gutknecht E; Van der Linden I; Olivares-Reyes JA; Dürrenberger F; Hauger RL
Biochem Pharmacol; 2004 Nov; 68(9):1833-44. PubMed ID: 15450949
[TBL] [Abstract][Full Text] [Related]
11. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
Brar BK; Chen A; Perrin MH; Vale W
Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
Choi KH; Rhim H
Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
[TBL] [Abstract][Full Text] [Related]
13. Imatinib-mesylate blocks recombinant T-type calcium channels expressed in human embryonic kidney-293 cells by a protein tyrosine kinase-independent mechanism.
Cataldi M; Gaudino A; Lariccia V; Russo M; Amoroso S; di Renzo G; Annunziato L
J Pharmacol Exp Ther; 2004 Apr; 309(1):208-15. PubMed ID: 14718589
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
15. Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
Stamboulian S; Kim D; Shin HS; Ronjat M; De Waard M; Arnoult C
J Cell Physiol; 2004 Jul; 200(1):116-24. PubMed ID: 15137064
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling.
Gutknecht E; Van der Linden I; Van Kolen K; Verhoeven KF; Vauquelin G; Dautzenberg FM
Mol Pharmacol; 2009 Mar; 75(3):648-57. PubMed ID: 19098121
[TBL] [Abstract][Full Text] [Related]
17. Effects of urocortin via ion mechanisms or CRF receptors?
Tao J; Li S
Biochem Biophys Res Commun; 2005 Oct; 336(3):731-6. PubMed ID: 16061206
[TBL] [Abstract][Full Text] [Related]
18. Making the T-type even tinier: corticotropin-releasing factor-mediated inhibition of low-voltage-activated calcium channel activity.
Varela DL; Hermosilla T; Zamponi GW
Mol Pharmacol; 2008 Jun; 73(6):1589-91. PubMed ID: 18326584
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N
Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
